Marty Makary, MD, was recently announced as President-Elect Trump’s pick to be the next commissioner of the Food and Drug Administration. In this episode from August 19, 2020, Dr. Makary, in conversation with Charles Overstreet, FTI Consulting, talks about the future of American medicine, including public health, price transparency, and issues related to access to care and appropriateness of care.